agilon health Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
agilon health Inc (AGL) PT Lowered to $4 at Deutsche Bank
August 8, 2024 4:08 PM EDTDeutsche Bank analyst George Hill lowered the price target on agilon health Inc (NYSE: AGL) to $4.00 (from $5.00) while maintaining a Hold rating.
The analyst comments "Another Revenue Miss: AGL reported Q2 results missing at the revenue line but making it up with the better-than-expected adjusted EBITDA. AGL reported total revenue of $1.48B (+38% yoy), below the... More
